CI
Cytokinetics Inc
🇺🇸XNAS.CYTKUnited StatesHealthcare
$70.06USDup +0.70 (+1.01%)OpenDelayed5:08 PM
Price$70.06+0.70 (+1.01%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23282W6057
- CUSIP
- 23282W100
Company
- Employees
- 673
- Headquarters
- South San Francisco, United States
- Website
- https://www.cytokinetics.com
- CEO
- Mr. Robert I. Blum
Market
- Shares outstanding
- 139M
- Market cap
- $9.74B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $9.64B
- EPS LTM
- -$6.77
- P/E LTM
- -12.76
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $70.96M-17.24%down year on year
- Net income
- -$894M-47.45%down year on year
- Gross margin
- 84.97%+137.43%up year on year
- Free cash flow
- -$580.71M-31.84%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.